ArticleSarcoma2018

SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy.

Edwin Choy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.